Teva Pharmaceutical Industries Limited logo

Teva Pharmaceutical Industries Limited

TEVA | NYSE
Chart Builder DCF Calculator
$39.23
-$0.83 (-2.07%)
Sep 22, 2026, 1:31 PM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Cash & Equivalents
3.56B 3.3B 3.23B 2.8B 2.17B 2.18B
Short-Term Investments
n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a 8M n/a n/a n/a
Other Long-Term Assets
404.99M 462M 462M 441M 515M 538M
Receivables
3.71B 3.06B 3.41B 3.7B 4.53B 4.58B
Inventory
3.18B 3.01B 4.02B 3.83B 3.82B 4.4B
Other Current Assets
2.38B 2.18B 575M 559M 986M 899M
Total Current Assets
13.95B 12.55B 12.49B 12.05B 12.57B 13.01B
Property-Plant & Equipment
4.42B 4.95B 6.15B 6.16B 6.48B 6.85B
Goodwill & Intangibles
19.78B 19.57B 22.56B 23.9B 27.51B 29.55B
Total Long-Term Assets
26.8B 26.77B 30.99B 31.96B 35.09B 37.63B
Total Assets
40.75B 39.33B 43.48B 44.01B 47.67B 50.64B
Account Payables
2.53B 2.2B 2.6B 1.89B 1.69B 1.76B
Deferred Revenue
n/a n/a n/a n/a n/a 7.29B
Short-Term Debt
1.82B 1.78B 1.67B 2.11B 1.43B 3.19B
Other Current Liabilities
8.37B 6.02B 5.2B 5.32B 5.71B 246M
Total Current Liabilities
13.46B 12.8B 12.25B 11.47B 11.03B 13.16B
Long-Term Debt
15.27B 16B 18.16B 19.1B 21.62B 22.73B
Other Long-Term Liabilities
3.52B 4.03B 4.02B 3.94B 2.58B 2.24B
Total Long-Term Liabilities
19.38B 20.81B 23.11B 23.94B 25.4B 26.42B
Total Liabilities
32.83B 33.61B 35.35B 35.41B 36.42B 39.58B
Total Debt
17.38B 18.08B 20.15B 21.56B 23.46B 26.4B
Book Value
7.91B 5.72B 8.13B 8.6B 11.24B 11.06B
Book Value Per Share
6.75 5.06 7.26 7.75 10.16 10.10
Common Stock
58M 58M 57M 57M 57M 57M
Retained Earnings
-13.76B -15.17B -13.53B -12.98B -10.53B -10.95B
Comprehensive Income
-2.39B -3.15B -2.7B -2.84B -2.68B -2.4B
Shareholders Equity
7.91B 5.37B 7.51B 7.8B 10.28B 10.03B
Total Investments
n/a n/a 8M n/a n/a n/a

© 2026 bestshares.com. All rights reserved.